Clearance in Primary Ciliary Dyskinesia
NCT07699302
Abnormalities, Multiple, Behavior
Chapel Hill, North Carolina, United States
View Trial DetailsNCT Number: NCT02704455
This study is a multicenter, prospective cohort study of patients diagnosed with primary ciliary dyskinesia, the clinical information of recruited patients, including clinical manifestations, lung function, chest imaging, quality of life and other indicators, will be followed for 10 years.
Trial opening soon.
Get NotifiedUp to 18 year
All sexes
Observational
All new cases of primary ciliary dyskinesia which was confirmed or diagnosed at each center from the beginning of the study are made the investigation of the clinical manifestations and specific tests by the standard diagnostic process.Then all the patients' following clinical data will be followed for 10 years (once per six month): clinical manifestations, lung function, chest imaging (once per year), quality of life and other indicators.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
A included patient must be coincident with all the following items:
Exclusion criteria
Subject will be excluded if she or he has one of the following:
Time frame: 10 years
forced expiratory volume at one second (FEV1) in Liter
Contact information is provided by the study sponsor or research team.
Beijing Children's Hospital
Other
Registry Study on Primary Ciliary Dyskinesia in Chinese children-a Multicenter, Prospective Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07699302
Abnormalities, Multiple, Behavior
Chapel Hill, North Carolina, United States
View Trial DetailsNCT03704207
Abnormalities, Multiple, Ciliary Motility Disorders
Nashville, Tennessee, United States
View Trial DetailsNCT00368446
Abnormalities, Multiple, Actinomycetales Infections
Bethesda, Maryland, United States
View Trial DetailsNCT05685186
Abnormalities, Multiple, Bronchial Diseases
Chapel Hill, North Carolina, United States
View Trial Details